Metabasis Therapeutics, Inc
(NASDAQ:MBRX)|
0.390 0.000 (0.00%) Jan 06 - Close |
|
|
|
After-Hours 0.43 +0.04 (10.26%) Wed, 7 Jan 2009 7:40 PM
- Compare MBRX with:
- View: Line | Candlestick
Company Profile
Metabasis Therapeutics, Inc
11119
La Jolla, CA 92037
United States - Map
Phone: (858) 587-2770
Fax: (858) 458-3504
Website: www.mbasis.com
CEO: Dr. Mark D. Erion, Ph.D.
Employees: 124
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Discover and develop drugs to treat liver disease
A biopharmaceutical company focused on discovering, developing and commercializing novel drugs by applying our proprietary technologies, scientific expertise and unique capabilities for targeting the liver and liver pathways.
Recent news for MBRX
-
METABASIS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online - Dec 15 2008 at 9:16 ET
-
Business Wire - Dec 15 2008 at 9:00 ET
-
METABASIS THERAPEUTICS INC Financials
EDGAR Online Financials - Nov 18 2008 at 9:04 ET
-
Metabasis Therapeutics Incorporated Q3 2008 Earnings Call Transcript
Seeking Alpha - Nov 13 2008 at 12:45 ET
-
Metabasis Therapeutics Earnings Call scheduled for 8:30 am ET today
CCBN - Nov 13 2008 at 8:30 ET
-
EDGAR Online - Nov 13 2008 at 6:02 ET
-
Business Wire - Nov 12 2008 at 8:00 ET
-
Q3 2008 Metabasis Therapeutics Earnings Release - After Market Close
CCBN - Nov 12 2008 at 7:07 ET
-
METABASIS THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 10 2008 at 4:34 ET
-
Metabasis Therapeutics Earnings Call scheduled for Thu, Nov 13
CCBN - Nov 04 2008 at 5:10 ET
